This HTML5 document contains 58 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
wdt	http://www.wikidata.org/prop/direct/
wdtn	http://www.wikidata.org/prop/direct-normalized/
schema	http://schema.org/
rdfs	http://www.w3.org/2000/01/rdf-schema#
skos	http://www.w3.org/2004/02/skos/core#
wikibase	http://wikiba.se/ontology#
p	http://www.wikidata.org/prop/
n10	http://dx.doi.org/10.1002/1097-0142(19820801)50:3%3C423::
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n8	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdh	http://www.w3.org/2001/XMLSchema#
wds	http://www.wikidata.org/entity/statement/
wd	http://www.wikidata.org/entity/

Statements

Subject Item

wd:Q70245493

rdf:type

wikibase:Item

schema:description

artículu científicu espublizáu n'agostu de 1982 wetenschappelijk artikel наукова стаття, опублікована в серпні 1982 im August 1982 veröffentlichter wissenschaftlicher Artikel scientific article published on 01 August 1982

p:P577

wds:Q70245493-90A208BB-72B3-4A1B-856C-DCE5138BB588

wdt:P577

1982-08-01T00:00:00Z

p:P407

wds:Q70245493-E745E505-233A-44AB-92E9-F6CA77FC710B

wdt:P407

wd:Q1860

p:P2093

wds:Q70245493-D5E67ECE-5EEE-44C6-9382-4554EA0CF8BF wds:Q70245493-C9B07A63-BE74-4569-B541-8B8FFAF4A345 wds:Q70245493-B3EA92C2-F9CE-4EAA-B50C-55C0E6F1200B wds:Q70245493-C064A27D-85FB-4224-AB1E-4F1B23ECF649 wds:Q70245493-951406D7-3442-4644-ABBA-0FABB37678BD wds:Q70245493-AFB63CD9-747A-490F-B015-CD9D09F9E917 wds:Q70245493-8DFBFDCF-9EDA-4F13-B556-EFA18DC201F5 wds:Q70245493-8E8FAFF7-8113-4597-AA42-6064A6E72C05 wds:Q70245493-754CA0C7-AC21-4B29-B10A-2D5C16DBB7EC wds:Q70245493-5CCBDBBF-4C32-4833-8F4B-C17C479E0700 wds:Q70245493-23329DD1-0D24-454E-94F6-3F4B54C9AE04

wdt:P2093

C Vaughn N Gad-el-Mawla B Tranum J Costanzi S Rasmussen H Glucksberg B Hoogstraten S E Rivkin J McCracken T Maloney J Athens

rdfs:label

Combination chemotherapy (CMFVP) versus L-phenylalanine mustard (L-PAM) for operable breast cancer with positive axillary nodes: a Southwest Oncology Group Study Combination chemotherapy (CMFVP) versus L-phenylalanine mustard (L-PAM) for operable breast cancer with positive axillary nodes: a Southwest Oncology Group Study

skos:prefLabel

Combination chemotherapy (CMFVP) versus L-phenylalanine mustard (L-PAM) for operable breast cancer with positive axillary nodes: a Southwest Oncology Group Study Combination chemotherapy (CMFVP) versus L-phenylalanine mustard (L-PAM) for operable breast cancer with positive axillary nodes: a Southwest Oncology Group Study

schema:name

Combination chemotherapy (CMFVP) versus L-phenylalanine mustard (L-PAM) for operable breast cancer with positive axillary nodes: a Southwest Oncology Group Study Combination chemotherapy (CMFVP) versus L-phenylalanine mustard (L-PAM) for operable breast cancer with positive axillary nodes: a Southwest Oncology Group Study

p:P1476

wds:Q70245493-F3CB6430-A486-48E6-8A6D-1EF52C3F5BA1

wdt:P1476

Combination chemotherapy (CMFVP) versus L-phenylalanine mustard (L-PAM) for operable breast cancer with positive axillary nodes: a Southwest Oncology Group Study

p:P304

wds:Q70245493-1F0CC8F6-1A83-43D8-A629-706E442F2260

wdt:P304

423-434

p:P31

wds:Q70245493-56DEC753-0A67-4D46-B9C3-8618698AC2CF

wdt:P31

wd:Q13442814

p:P698

wds:Q70245493-E586BFE1-A520-4934-9A34-31B588F968B7

wdtn:P698

n8:7046900

wdt:P698

7046900

p:P1433

wds:Q70245493-8F0F4381-FA66-4694-871A-DEAD304FC91E

wdt:P1433

wd:Q326041

p:P433

wds:Q70245493-D4226581-1AC0-4137-8FA9-A4630C8B5998

p:P478

wds:Q70245493-E7BB1681-9D7D-4E84-ABA9-4756044736A3

wdt:P433

3

wdt:P478

50

p:P1104

wds:Q70245493-1D69A021-C499-4FC5-85EB-B8CA81F10B7E

wdt:P1104

12

p:P356

wds:Q70245493-71DC9A6F-F814-4C14-A7FF-6D21B7E66F17

wdtn:P356

n10:AID-CNCR2820500307%3E3.0.CO;2-O

wdt:P356

10.1002/1097-0142(19820801)50:3<423::AID-CNCR2820500307>3.0.CO;2-O